CD4 and Glucose intolerance: Based on this evidence and on the limited impact of B. uniformis administration on the abundance of other bacteria (Fig. 5C), we hypothesized that B. uniformis could directly modulate CD4+ T cells during its transit through the small intestine to help mitigate HFHSD-induced inflammation and glucose intolerance.